Clover Health (CLOV) exec uses 6,197 vested shares for taxes

Rhea-AI Filing Summary

Clover Health Investments executive Jamie L. Reynoso, CEO, Medicare Advantage, had 6,197 shares of Class A Common Stock withheld on April 3, 2026 to cover tax obligations. The withholding related to the vesting of 6.25% of restricted stock units granted on January 3, 2023.

After this tax-withholding disposition, Reynoso directly holds 2,869,922 shares of Class A Common Stock. The remaining RSUs from the 2023 grant will vest in equal quarterly installments through January 3, 2027, subject to Reynoso’s continued service on each vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Reynoso Jamie L.

Role CEO, Medicare Advantage

Type	Security	Shares	Price	Value
Tax Withholding	Class A Common Stock	6,197	$1.72	$11K

Holdings After Transaction: Class A Common Stock — 2,869,922 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 6,197 shares Price per share for withholding: $1.72 per share Shares held after transaction: 2,869,922 shares +2 more

5 metrics

Shares withheld for taxes 6,197 shares Class A Common Stock withheld on April 3, 2026

Price per share for withholding $1.72 per share Value used for 6,197-share tax-withholding disposition

Shares held after transaction 2,869,922 shares Direct Class A Common Stock ownership after April 3, 2026

Vested RSU portion 6.25% of RSUs Portion of January 3, 2023 RSU grant vesting on April 3, 2026

Final RSU vesting date January 3, 2027 End of equal quarterly vesting schedule, subject to continued service

Key Terms

restricted stock units ("RSUs"), vesting, tax obligations, Class A Common Stock, +1 more

5 terms

restricted stock units ("RSUs") financial

"vesting on April 3, 2026, of 6.25% of the restricted stock units ("RSUs") granted"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vesting financial

"were automatically withheld to cover tax obligations due to the vesting on April 3, 2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

tax obligations financial

"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations"

Class A Common Stock financial

"Represents shares of Class A Common Stock that were automatically withheld"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

equal quarterly installments financial

"The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reynoso Jamie L.

(Last) (First) (Middle)

C/O CLOVER HEALTH INVESTMENTS, CORP.

NOT APPLICABLE

(Street)

WILMINGTON DELAWARE 19801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Medicare Advantage

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/03/2026		F		6,197(1)	D	$1.72	2,869,922	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2026, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

Remarks:

	/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Clover Health (CLOV) executive Jamie Reynoso report in this Form 4?

Jamie L. Reynoso reported a tax-withholding disposition of 6,197 shares of Class A Common Stock. These shares were automatically withheld to cover tax obligations triggered by the vesting of previously granted restricted stock units on April 3, 2026.

Why were 6,197 Clover Health (CLOV) shares withheld from Jamie Reynoso?

The 6,197 shares were withheld to satisfy tax obligations arising from RSUs vesting on April 3, 2026. This occurred when 6.25% of the RSUs granted on January 3, 2023 vested, as part of Reynoso’s equity compensation package and standard tax treatment.

How many Clover Health (CLOV) shares does Jamie Reynoso hold after this transaction?

Following the tax-withholding disposition, Jamie L. Reynoso directly holds 2,869,922 shares of Class A Common Stock. This figure reflects her updated direct ownership after the automatic share withholding to cover taxes tied to RSU vesting.

What is the vesting schedule of Jamie Reynoso’s Clover Health RSUs from 2023?

The RSUs granted on January 3, 2023 vest in equal quarterly installments. A 6.25% portion vested on April 3, 2026, and the remaining RSUs will continue vesting quarterly, with final vesting scheduled for January 3, 2027, subject to continued service.

Was Jamie Reynoso’s Clover Health Form 4 an open-market sale of shares?

No, the Form 4 reports a tax-withholding disposition rather than an open-market sale. Shares of Class A Common Stock were automatically withheld by the company to cover tax obligations due on the vesting of restricted stock units granted as compensation.